Shipment courier

TAAT® ships largest UK shipment yet for Expanded

With the largest UK TAAT® shipment to date expected to arrive this quarter, the company’s UK TAAT® distributor plans to expand the brand’s footprint into other markets in the South East region. east of the country.

LAS VEGAS and VANCOUVER, British Columbia, Sept. 16, 2022 (GLOBE NEWSWIRE) — TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) is pleased to announce that it has shipped a “full container” shipment of TAAT® to the UK, marking the company’s largest shipment to the UK to date, approximately three times the amount of product previously sent. This shipment will be used to further expand the distribution of TAAT® outside of the Greater London area into additional markets in the South East region of the UK, which the Company is currently coordinating with Green Global Earth (“GGE”) , its British wholesale partner. .

TAAT® CEO Michael Saxon said: “So far 2022 has been an adventure as we have expanded internationally in the UK. Some of the challenges we faced in the supply chain are usual, especially for a new product like TAAT®. We believe we are at the end of these initial hurdles and can start shipping more regularly to the UK as the number one international market. I was in London earlier this week, working directly with our partners at GGE to plan exactly how we will deliver our next UK expansion, and will be back later this year to discuss our plans for 2023.”

TAAT® CEO Michael Saxon (left) is pictured with GGE CEO John Hilton (right) at InterTabac in Dortmund, Germany. Mr. Saxon and Mr. Hilton are currently aligning the resources of TAAT® and GGE to optimize the growth-stage commercialization of TAAT® products in the UK as GGE prepares to receive its largest delivery to date from the Company. .

Readers using news aggregation services may not be able to view the above media. Please access SEDAR or Investor Relations section of the Company’s website for a version of this press release containing all published media.

In a press release dated July 22, 2022, TAAT® announced that it had received a third order from GGE, which was particularly excited to receive TAAT® made with Beyond Tobacco™ “V3”. Adult smokers in the US and UK have reported that the V3 smoking experience is pleasant and more like the smoking experience of regular tobacco, although it does not contain nicotine. At the time of this writing, TAAT® is primarily sold in South London; a presence that the Company and GGE intend to leverage to organically establish an expanded footprint in new markets in neighboring regions.

On behalf of the Company’s Board of Directors,


“Michael Saxon”

Michael Saxon, CEO and Director

For more information, please contact:

TAAT® Investor Relations
1-833-TAAT-USA (1-833-822-8872)
[email protected]


About TAAT® Global Alternatives Inc.

TAAT® develops, manufactures and distributes alternative products in categories such as tobacco, hemp, kratom and other emerging CPG segments. Its flagship product is a nicotine- and tobacco-free fuel with a patent-pending base material formulation, sold in several thousand stores across the United States. With over $80 million CAD in annual gross revenue, TAAT® facilities include an operations center in Nevada, as well as a distribution center and multiple convenience stores in Ohio.

For more information, please visit

Forward-looking statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Often, but not always, forward-looking information and information can be identified by the use of words such as “anticipates”, “expects” or “does not expect”, “is expected”, “estimates “, “intends to”, “anticipates” or “does not anticipate”, or “believes”, or variations of these words and expressions or declare that certain actions, events or results “may”, “might” , “would”, “might” or “will” take, occur or be realized. The forward-looking information in this press release includes statements regarding the anticipated performance of TAAT® in the tobacco industry, in addition to following: final delivery of full container shipment of TAAT® to the UK, planned expansion of TAAT® outside of Greater London, potential results of marketing and commercialization efforts of TAAT® in the UK targeting adult smokers and retailers from which they would usually buy tobacco products. Forward-looking information reflects management’s current expectations based on information currently available and is subject to a number of risks and uncertainties that could cause actual results to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in the preparation of the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur within the time periods disclosed or not. at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes in the growth and size of tobacco markets; (iii) changes in the regulatory landscape applicable to the Company’s activities; and (iv) other factors beyond the Company’s control. The Company operates in a rapidly changing environment. New risk factors emerge from time to time, and it is impossible for the management of the Company to predict all risk factors, nor can the Company assess the impact of all factors on the business of the Company. Company or the extent to which any factor, or combination of factors, could cause actual results to differ from those contained in the forward-looking information. The forward-looking information included in this press release is made as of the date of this press release, and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. , except as required by applicable law.

The statements in this press release have not been evaluated by Health Canada or the United States Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claim or warranty can be made as to the effects of the Company’s products on the health and well-being of any individual. The Company’s products are not intended to diagnose, treat, cure or prevent any disease.

This press release may contain brand names of third-party entities (or their respective offerings with brand names) generally in reference to (i) the Company’s relationships with the third-party entities mentioned in this press release and/or (ii ) customers/suppliers/service providers whose relationship with the Company is/are mentioned in this press release. All rights in and to these marks are reserved by their respective owners or licensees.

Statement Regarding Third-Party Investor Relations Firms

Information about the investor relations firms retained by TAAT® Global Alternatives Inc. can be found under the company profile on

A photo accompanying this announcement is available at